Surprisingly, circulating SOD levels have been observed to be elevated in a disease‐severity manner among those hospitalized with COVID‐19 (Mehri et al., 2021), which may be a remedial mechanism to counteract the effects of high oxidative stress. The gene discussed is SOD1; the disease is COVID-19.